As of January 2026 Adaptive Biotechnologies has a market cap of $2.67 Billion USD. This makes Adaptive Biotechnologies the world's 4215th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 17th, 2026 the market cap of Adaptive Biotechnologies was reported to be: